Huntsman Corporation 10-Q Summary: Q2 2024
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2024, for Huntsman Corporation and its wholly-owned subsidiary, Huntsman International LLC. Huntsman is a global manufacturer of diversified organic chemical products operating in three segments: Polyurethanes, Performance Products, and Advanced Materials. The company operates globally, with significant exposure to industrial and building product markets.
Key Financial Metrics (Six Months Ended June 30, 2024)
| Metric | 2024 (YTD) | 2023 (YTD) |
|---|---|---|
| Total Revenues | $3,044 million | $3,202 million |
| Gross Profit | $444 million | $523 million |
| Operating Income (Loss) | $(4) million | $111 million |
| Net Income (Loss) Attributable to Huntsman | $(15) million | $172 million |
| Adjusted EBITDA | $212 million | $292 million |
| Cash and Cash Equivalents | $335 million | $540 million (Dec 31, 2023) |
| Total Debt | $1,920 million | $1,688 million (Dec 31, 2023) |
| Free Cash Flow | $(100) million | $(179) million |
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 5% year-over-year, driven primarily by lower average selling prices across all segments due to competitive pressures and unfavorable supply/demand dynamics, partially offset by higher sales volumes.
- Profitability Impact: Operating income turned negative for the six-month period compared to a profit of $111 million in 2023. This was significantly impacted by a $71 million prepaid asset write-off and $15 million in restructuring costs, partially offset by a $51 million gain on the acquisition of assets from the SLIC joint venture.
- Segment Performance:
- Polyurethanes: Adjusted EBITDA fell 23% due to lower MDI prices.
- Performance Products: Adjusted EBITDA fell 30% due to competitive pricing pressure.
- Advanced Materials: Adjusted EBITDA declined 4% due to higher fixed costs.
- Liquidity: Working capital decreased by $617 million, largely due to a $564 million increase in the current portion of debt (including $245 million drawn on the revolving credit facility and $320 million in senior notes maturing in 2025).
Guidance, Outlook, and Risks
- Capital Expenditures: The company expects to spend between $180 million and $200 million on capital expenditures for the full year 2024.
- Restructuring: The company expects to incur approximately $11 million in further restructuring expenses through 2025 related to the Advanced Materials segment and $2 million for other programs.
- Legal Contingency: A favorable $93.1 million jury verdict against Praxair/Linde was affirmed in April 2024. With interest, damages are expected to exceed $135 million, with net proceeds estimated at $50–$60 million. This amount has not yet been recognized in earnings.
- Dividends: The Board declared a $0.25 per share dividend for Q2 2024, a 5% increase from the prior year.
- Share Repurchases: No shares were repurchased under the $2 billion program during the first half of 2024. Approximately $547 million remains authorized.
Investor Verification Checklist
- Debt Maturity Wall: Verify the refinancing strategy for the $320 million in 2025 Senior Notes and the $245 million in revolving credit facility usage, which now comprise the majority of current liabilities.
- SLIC Transaction Accounting: Confirm the finalization of the $51 million bargain purchase gain and the $71 million prepaid asset write-off related to the SLIC joint venture separation.
- Legal Proceeds Timing: Monitor the timeline for the collection of the Praxair/Linde judgment proceeds, as this represents a significant potential cash inflow not yet booked.
- Margin Compression: Assess the sustainability of selling price declines in the Polyurethanes and Performance Products segments against raw material cost trends.
- Free Cash Flow: Review the drivers behind the negative free cash flow of $100 million for the period and the outlook for cash generation in the second half of the year.